AbbVie: Balance Is Everything (NYSE:ABBV)

Adalimumab Prescription


The Decline of Humira

For the first seven years of AbbVie’s (NYSE:ABBV) existence as a public company, its top selling drug Humira made up over 60% of the company’s total sales on average. By some accounts, based on cumulative sales

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *